SOPHiA GENETICS (SOPH) Cash from Financing Activities (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Cash from Financing Activities data on file, last reported at -$385000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities rose 67.04% year-over-year to -$385000.0; the trailing twelve-month figure through Dec 2025 stood at $30.2 million (up 206.15% YoY), and the FY2025 full-year result was $30.2 million, up 206.15% from the prior year.
• Cash from Financing Activities climbed to -$385000.0 in Q4 2025, from -$2.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $237.7 million in Q3 2021 to a low of -$2.0 million in Q3 2025.
• A 5-year average of $13.7 million and a median of -$599500.0 in 2022 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities slumped 366.81% in 2023 and surged 2187.56% in 2024, its largest moves.
• Tracing SOPH's Cash from Financing Activities over 5 years: stood at -$447000.0 in 2021, then fell by 29.75% to -$580000.0 in 2022, then advanced by 11.72% to -$512000.0 in 2023, then slumped by 128.12% to -$1.2 million in 2024, then soared by 67.04% to -$385000.0 in 2025.
• Business Quant data shows SOPH's Cash from Financing Activities at -$385000.0 in Q4 2025, -$2.0 million in Q3 2025, and $33.5 million in Q2 2025.